The Atlanta Journal-Constitution

Hoping for healthier 2022

There are many reasons, in fact, to be cautiously optimistic as we leave the woes of 2021 behind.

- By Steven Petrow |

This year sure wasn’t supposed to be this way. After the long, locked-down nightmare that was 2020, 2021 dawned with the promise that vaccines would soon be widely available and bring an end to the horrifying death toll and a return to “normal” life. A few months into the year, President Joe Biden promised we’d be celebratin­g the Fourth of July the old-fashioned way — together.

Not so fast. Instead, we argued about conspiracy theories and the constituti­onal right to go unmasked, while the virus continued to circulate (and mutate) and take more lives. About 61.9% of the population is fully vaccinated, far short of the Biden administra­tion’s hopes. Then came delta. And now omicron.

Incredibly, more Americans have died of this virus in 2021, with vaccines readily available, than in 2020. Suddenly, it seems, the light at the end of the tunnel has dimmed if not gone out.

Facing yet another year of illness and death, how could any of us be optimistic about 2022? Why should anyone be optimistic? Why should anyone believe things will ever get better?

And yet, there is reason for hope — many reasons, in fact.

Buried under the layers of grief and loss, there are seeds of hope. Hope that science will prevail. Hope for new treatments and cures for the coronaviru­s and many other illnesses. Hope that life will get better, that our loved ones will stop dying and that this pandemic will become a dark memory instead of a daily reality.

Who’s resilient? Why you are

“I think people can look forward to appreciati­ng just how resilient they are by taking a look back at how they’ve endured the past two years,” says Richard A. Friedman, a psychiatri­st at Newyork-presbyteri­an and Weill Cornell Medicine.

More than 7 in 10 Americans, ages 50 to 80, said they feel the same level of resilience — overcoming challenges, recovering and bouncing back from adversity — as they did before the pandemic, according to the University of Michigan National Poll on Healthy Aging. And 15 percent said they actually felt more resilient.

“Adversity is painful,” Friedman said, “but it can also make us stronger and better.”

We’ve learned what precaution­s to take to once again (mostly) live our lives

Biden was right when he said last week, “This is not March 2020.” Nearly two years into the pandemic, we better understand how to take care of ourselves and our loved ones: get vaccinated and boosted, wear masks indoors, keep a distance and get tested.

Coronaviru­s testing and treatment, not just vaccines, will be the linchpins to the fight against coronaviru­s in 2022, says Arthur Caplan, professor of bioethics at New York University, who argues draconian measures like lockdowns no longer work and it’s time to move onto new strategies of containmen­t.

Most schools and colleges reopened this year, as did some workplaces, and airports were once again packed this holiday season. N95 and KN95 masks are widely available online and in stores, as are disinfecti­ng wipes and sprays. (And, hurrah, toilet paper!) Starting in January, the federal government plans to distribute hundreds of millions of free at-home tests and to expand coronaviru­s testing sites across the country. And this month, the Food and Drug Administra­tion approved two pills that high-risk patients with coronaviru­s can take at home to greatly reduce their chances of being hospitaliz­ed.

Free coronaviru­s vaccines and booster shots are (finally) widely available

Your best defense against COVID-19, the disease caused by the coronaviru­s, is to be fully vaccinated. One year ago, vaccines were mostly available to only health care workers. For months in early 2021, most of us had to anxiously wait our turns to get a jab or two. As this new year dawns, vaccines are now widely available free to anyone over age 5. Booster shots are also available to most adults, and early data indicates these shots will provide greater protection against the omicron variant and will reduce the likelihood of serious illness or death.

The success of MRNA vaccines bodes well for cancer treatments

The Pfizer and Moderna shots are messenger RNA (MRNA) vaccines. The use of MRNA has long intrigued researcher­s in treating a number of other diseases, including flu, Zika, rabies and cytomegalo­virus. Researcher­s now think that MRNA can be used to rapidly create safe and effective vaccines to treat cancer. One example: Memorial Sloan Kettering Cancer Center trials are underway testing MRNA vaccines against pancreatic cancer, one of the deadliest malignanci­es. This clinical trial is a year ahead of schedule, despite the challenges to perform such a complex study in the middle of a pandemic, said Vinod Balachandr­an, a surgeon-scientist at Sloan Kettering.

And we’re winning the war on cancer — slowly

Fifty years ago, President Richard Nixon officially declared war on cancer, with the hope of eradicatin­g cancer within the decade. While that didn’t happen, there has been slow but real progress in our understand­ing of cancer and in extending longevity and decreasing death rates. During that time frame, deaths from colorectal cancers decreased more than 50 percent and breast cancer by 40 percent, according to the American Cancer Society. When it comes to lung cancer, the No. 1 cancer killer, five-year survival rates have improved due to immunother­apies and targeted therapies.

Five years ago in December, Congress passed the 21st Century Cures Act, which dedicates $1.8 billion in funding for cancer research over seven years — and cancer patients are now benefiting.

Scientists are regaining trust

The past two years revealed just how many Americans refuse to believe scientists, as the internet filled with misinforma­tion and conspiracy theories about the pandemic, coronaviru­s treatments and vaccine safety. But according to a public-opinion poll conducted August 2020 to February 2021 by Gallup, 54% of Americans said they had “a lot” of trust in scientists, which was up nine percentage points from 2018, according to a report published in November by Wellcome Trust, a health research foundation in London. Around the world, 43% of people surveyed in 113 countries said they trust scientists “a lot,” an increase from 34% in 2018.

The FDA approved new shot to prevent HIV

The news is looking up for combating other viruses, too. Until last week, the only PREP (pre-exposure prophylaxi­s) medication­s approved by the FDA were pills required to be taken daily, which for some proved challengin­g or unrealisti­c. When taken every day, PREP pills can reduce the risk of getting HIV from sex by as much as 99 percent, but the Centers for Disease Control and Prevention says it’s “much less effective when it is not taken as prescribed.”

Starting early in 2022, people will have another tool to fight transmissi­on of HIV, an injectable drug called Apretude, given first as two injections one month apart and then once every two months. The FDA approved it for “at risk” adults and teens weighing at least 77 pounds. Researcher­s say Apretude had been found to be more effective than previous PREP medication­s like Truvada and Descovy at preventing HIV infection from sex. The new jab gives us another shot at ending HIV.

Say buh-bye to West Nile, Zika and malaria

Genetic engineerin­g of mosquitoes will finally make a real dent in malaria case numbers and may also help get rid of other insect-borne diseases. Scientists reported in 2020 that they eradicated an entire population of malaria-transmitti­ng mosquitoes by deploying a radical form of genetic engineerin­g to render females infertile and therefore unable to reproduce. (In 2019, more than 400,000 deaths from malaria were recorded worldwide.) New trials are slated to start within the next few years, bringing fresh hope in the battle against one of the world’s biggest killers, which could result in self-destroying mosquitoes being released within the coming decade.

Some employers are offering more health benefits

The pandemic has led to many changes in the workplace, and employees in some industries are gaining power — and, often, access to better health insurance and more sick days. Federal law doesn’t require businesses with fewer than 50 employees to provide health, dental or vision insurance, but some small businesses that are struggling to hire have found they must offer such benefits. Surveys of employers and human resources profession­als found an uptick in offerings this year.

Finding community online can be a very good thing

We’ve learned the benefits of joining virtual groups for all types of things, such as cancer support, business meetings and yoga classes. They pull down barriers and open up access — and many groups plan to continue offering virtual options in 2022, even as gathering in person, we hope, becomes safer. Teletherap­y options grew exponentia­lly amid the pandemic, which many therapists say has made it easier for those struggling with mental health issues to seek help and make it to their appointmen­ts. No worries about parking.

Being outdoors is good for our health

Fran Lebowitz, the New York author, once said, “To me the outdoors is what you must pass through in order to get from your apartment into a taxicab.” If that was you pre-pandemic, you’ve probably changed your ways as you started dining alfresco and frequentin­g farmers markets. Maybe you even enjoyed an outdoor concert? Took a hike?

It’s a good thing to be outside more, according to multiple studies. Those benefits include lower blood pressure and reduced stress, improved mood, and decreased anxiety and depression, better focus and even quicker healing. One study reported patients who spent time outdoors upon discharge after surgery required fewer painkiller­s, had fewer complicati­ons and experience­d shorter hospital stays. And don’t forget the Japanese practice of shinrin-yoku or forest bathing, which could improve cardiovasc­ular and mental health.

 ?? CRAIG RUTTLE/ASSOCIATED PRESS ?? People line up Dec. 23 to receive test kits to detect COVID-19 in New York. Coronaviru­s testing and treatment, not just vaccines, will be the linchpins to the fight against coronaviru­s in 2022, says Arthur Caplan, professor of bioethics at New York University.
CRAIG RUTTLE/ASSOCIATED PRESS People line up Dec. 23 to receive test kits to detect COVID-19 in New York. Coronaviru­s testing and treatment, not just vaccines, will be the linchpins to the fight against coronaviru­s in 2022, says Arthur Caplan, professor of bioethics at New York University.

Newspapers in English

Newspapers from United States